The past six months have seen an unprecedented rate of change for both the global and European cannabis industry. Today, for the first time, patients across the United Kingdom will be able to be prescribed a range of cannabis-based medicinal products.

Canada has a unique opportunity in emerging European medical cannabis markets. However, Europe is a complex patchwork of challenges and opportunities that only the most astute will be able to successfully capitalise on. 

January 1st was a momentous day for the cannabis industry and drug policy reform globally. A week ago, when the clock struck midnight, California began legal sales of cannabis for adult use.